Zhang X G, Chan M K
First Affiliated Hospital, Sun Yen Sen Medical University, Guangzhou, Hong Kong.
Int Urol Nephrol. 1994;26(5):587-93. doi: 10.1007/BF02767664.
The incidence of cytomegalovirus infection in Chinese patients was reviewed in a retrospective study of 99 renal transplant recipients. CMV infection occurred in 18 patients (18.2%). In 4 the infection was considered primary and in 14 it was thought to be reactivation. Of the infections 88.9% occurred within the first 6 months after transplantation, 44.4% were asymptomatic, while the rest had protean manifestations with the commonest combinations of fever, hepatic dysfunction and haematological abnormalities. One patient succumbed to the infection. Significant difference was seen in the incidence of CMV infections among patients who had received different antirejection therapy, being the highest (37%) among those who had received either Atgam or OKT3. Among the various secretions, urine gave the best yield of virus cultures.
一项对99例肾移植受者的回顾性研究评估了中国患者巨细胞病毒感染的发生率。18例患者(18.2%)发生了巨细胞病毒感染。其中4例感染被认为是原发性的,14例被认为是再激活。88.9%的感染发生在移植后的前6个月内,44.4%的感染无症状,其余患者有多种表现,最常见的组合是发热、肝功能障碍和血液学异常。1例患者死于感染。接受不同抗排斥治疗的患者中巨细胞病毒感染发生率存在显著差异,接受抗胸腺细胞球蛋白(Atgam)或OKT3的患者中发生率最高(37%)。在各种分泌物中,尿液的病毒培养阳性率最高。